Analysts Issue Forecasts for RNA FY2026 Earnings
Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for shares of Avidity Biosciences in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt expects that the biotechnology company will earn ($5.15) per share for the year. The consensus estimate […]
